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The recent finding that more than one InRuenza hemagglutinin (HA) is required at the fusion site for HA-expressing fibroblasts [l), together with 
the crystal structure of HA at neutral pH [2], provide the basic elements of a plausible model for this fusion site. Within an aggregate of HA trimers 
at low pH, we propose fusion intermediates which are based upon a minimal alteration to the known neutral pH structure of HA and which should 
have reasonable activation energies. This is the first model of a g~ycoprotein-media~d fusion site which explicitly accounts for the ~sposition of 
the lipids within these intermediates. While the fusion site created by HA will not be the same as that of eukaryotic fusion complexes [3], general 
characteristics ould be shared. 
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1. INTRODUCTION 
Ten years ago, the X-ray crystallographic structure of 
the bromelain-released, soluble ectodomain of the 
(A/Aichi/Z/68) In~uenza envelope glycoprotein 
hemagglutinin (BHA) was solved [2]. Soon after, BHA 
and the intact hemagglutinin (HA) were shown to 
undergo similar conformational changes at the pH 
associated with fusion between the viral envelope and a 
target membrane 141. As a mature protein, HA consists 
of two poIypeptide chains linked by a single disuIfide 
bond. HA1 contains the sialic acid binding site of HA 
[5]. The N-terminal region of the HA2 subunit is a 
highly conserved apolar sequence which is exposed at 
low pH [6] and which can control the fusion function of 
HA [7]. These 20 or so amino acids are referred to as the 
fusion peptide sequence of HA 1781. 
While many molecular details of the low pH-induced 
conformational changes of HA are known [6-151, it is 
not known how HA actually induces fusion. A crucial 
parameter for elucidating the architecture of the fusion 
site, i.e. the arrangement of the fusion proteins and the 
lipid bilayers, is the number of HAS at the fusion site. 
To determine this number, it is necessary to measure fu- 
sion efficiency as a function of HA surface density [ 161. 
surface densities. Fluorescence recovery after 
photobleaching showed that the HAS on both cell lines 
had the same lateral diffusion coefficients and the same 
mobile fractions, which indicates that there was no 
significant difference between the HAS expressed on the 
plasma membranes of both cell lines. Fusion efficiency 
was measured using glycophorin bearing liposomes 
(diameter -0.5 lm). These liposomes were shown to 
bind to the HA-expressing cells specifically through 
HA-glycophorin interactions. Surprisingly, it was 
found that the low pH induced fusion between the cells 
and bound liposomes was mediated by HAS not bound 
to glycophorin. Thus, while each HA has a binding 
function and a fusion function, these functions are not 
carried out by the same HA. The other significant 
finding was rigorous proof that more than one HA 
trimer is required to induce fusion. This had been 
speculated previously [ 1 I ] and a few studies have aimed 
at deducing this minimal fusion unit, using indirect 
methods for altering the surface density of ‘fusogenic’ 
HA on Influenza virus or HA-expressing cells [17,18]. 
2. PROPOSAL 
Ellens et al. [l] studied this problem using two NIH 
3T3 fibroblast cell lines which stably express the HA 
from the Japan strain of Influenza virus at different cell 
Correspondence address: J. Bentz, Department of Bioscience and 
Biotechnology, Drexel University, Philadelphia, PA 19104, USA 
These findings ied us to reconsider the mechanism of 
HA-induced fusion. In particular, we sought to account 
for the disposition of the bilayer lipids within fusion in- 
termediates which qualitatively minimize the activation 
energy of the process. The model which we propose has 
three separate elements. Firstly, we propose that the 
HAS at the fusion site form a ‘collar’ and that fusion of 
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the membranes occurs within this collar. Secondly, we 
propose that the role of the fusion peptide is to 
dehydrate the interior of this collar, which induces a 
wetting of the HAS by the lipids in the membranes. This 
is the initial step of membrane destabilization. Thirdly, 
we propose that the fusion peptide accomplishes this 
dehydration and wetting not by inserting into either 
membrane, but rather by residing between the apposed 
membranes, where its hydrophobic potential draws the 
lipids from both bilayers into the fusion site. We will 
describe this model first and then discuss how it differs 
from previous descriptions of HA-induced fusion, 
The essential difference between an isolated HA 
trimer and a multimer of HA trimers is the space within 
the muItimer, e.g. where the HAs could form a ‘collar’. 
This space is a natural candidate for the fusion site. 
Since the assay for fusion used in Ellens et al. [l] was 
the transmission of a soluble, liposome-encapsulated, 
30 kDa plant toxin into the cells, it was evident hat pro- 
per fusion through a pore had been achieved. In Fig. 1, 
a top-view of a lipid-lined fusion pore surrounding an 
aqueous channel is shown. Rigorously, we only know 
that more than one HA is at the fusion site, but it does 
not seem likely from scale modelling that only two HAS 
would be sufficient. Thus, we show three HAS at this 
fusion site, although this choice is arbitrary. The am- 
phipathic N-terminus of HA2 is shown as an a-helix at 
the oil/water interface of the lipid-lined pore and as a 
random coil in the aqueous space [8,14,15]. The 
diameter of the pore shown is about 4 nm, which is the 
estimated initial pore size for the fusion of the HA- 
expressing cells with erythrocytes [19,201. 
How does the aggregation of HA trimers create the 
fusion site? We propose that at low pH, the close ap- 
proach of HA trimers with exposed amphipathic fusion 
Fig. 2. Proposed structures of the HA fusion intermediates. (A) Close 
approach of two or more HA trimers, with the exposed ampbipathic 
fusion peptides, dehydrates the ifltermembrane space, which permits 
the formation of a closed jntermembrane intermediate, like an in- 
verted micelle. The HAi globular headgroups for the Japan strain do 
not dissociate 1251, as discussed in the text. The packing of the lipids 
near the transmembrane domains and the tops of the HA1 
headgroups are not specified. (B) A cut-away view of the in- 
termediate, showing the aqueous core. (C) The unstable intermem- 
brane intermediate shown in part (A) will either revert to two apposed 
membranes or it will break perpendicuIar to the membranes and form 
Fig. 1. Top view of the proposed lipid-lined fusion pore, with an 
aqueous channel, created by three HA trimers at low pH. The exposed 
fusion peptides are n-helices at the interfaces between the acyl chains 
and the medium, and they are random coils when exposed to just the 
aqueous medium {8,14,15]. the lipid-lined fusion pore shown here. 
peptides dehydrates the intermembrane space within the 
collar, which promotes the wetting of the inner surface 
of the HAS in the collar. This is shown by the formation 
of a localized lipid intermembrane intermediate (Fig. 
2A). HAS bound to glycophorin are not shown since 
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they are not directly involved in fusion [l]. The cut- 
away view in Fig. 2B shows the aqueous core of the in- 
termediate. This intermediate is unstable and either will 
revert to the apposed membranes, or it will break 
perpendicular to the membranes and form an in- 
terlamellar attachment. Fig. 2C shows a cut-away view 
of this interlamellar attachment, i.e. the lipid-lined fu- 
sion pore. Fig. 1 serves as a top-view for the structures 
shown in Fig. 2. In pure lipid systems, the formation of 
intermembrane intermediates and interlamellar attach- 
ment sites (similar to those shown here), as well as their 
mediation of liposome fusion, have been very well 
characterized 121-231. The conductance and 
capacitance flickering observed by Spruce et al. 1201 
prior to the complete fusion of HA-expressing cells with 
erythrocytes would be explained by breakage of the 
pore and reformation of the apposed membranes. After 
pore formation, the HAS will diffuse apart, thereby 
widening the pore and completing the fusion event. 
Knoll et al. [24] have shown freeze-fracture images 
from Influenza virus infected cells fusing with 
Fig. 3. The secondary structure of the HA monomer is shown at 
neutral pH (adapted from Wilson et al. [2] and Ruigrok et al. [9]). The 
HA1 globular headgroups contain the sialic acid binding site for HA, 
shown by the dark spot on HAl, which is the site of glycophorin bin- 
ding. The fibrous HA2 bodies contain the fusion peptide at the N- 
terminus, which is tucked into the center of the trimer at neutral pH 
and exposed at low pH [2,6]. Following the low pH treatment, the fu- 
sion peptide is exposed and we propose that its motion is restricted to 
within the area demarked by the dashed line, due to constraints in 
secondary and tertiary structure. Only the monomer is being shown 
here for clarity, but it is important to recall that the HA trimer re- 
mains intact at low pH [ll]. 
liposomes which are consistent with the structures 
shown in Fig. 2C (see also [23]). 
Dissociation of the globular HA1 subunits is’known 
to occur following low pH treatment’ with many In- 
fluenza virus strains, including A/Aichi/2/68 [6]. En- 
terestingly, for the Japan strain used in Ellens et al. 111, 
it has been reported that this dissociation does not occur 
and does not represent a necessary step in fusion [25]. 
Thus we show the HAls in an undissociated conforma- 
tion during fusion. Our model does not depend upon 
whether dissociation occurs. It is only a question of 
whether the distance between the membranes at the fu- 
sion site is 9 or 13 run, these being the heights of the 
HA2 trimer and the intact HA trimer, respectively. This 
distance could be shortened by having the HAS ‘lie 
down’ onto the membrane surface, but this entails 
postulating additional conformational changes to HA. 
In Fig. 3, we show why it is reasonable to speculate 
that the fusion peptide of HA acts between the apposed 
membranes, rather than inserting into either one. The 
secondary structure of the HA monomer (for 
A/Aichi/2/68) is shown at neutral pH (adapted from 
Wilson et al. 121 and Ruigrok et al. 291). About 30 
amino acids in from the N-terminus, the polypeptide se- 
quence of HA2 forms into two strands of a five strand- 
ed P-sheet, where the other three strands derive from 
distal portions of the HA monomer [2]. After these two 
strands, the polypeptide chain directly forms into a 
small a-helix, which is conjugated with the main o-helix 
of the fibrous stem of HA2 131. So Iong as these parts 
of the secondary and tertiary structure remain intact 
after the low pH treatment, the exposed a-helical N- 
terminus of HA2 will be confined to the area outlined 
by the dashed line. The -40 A radius of this 
hemisphere is the length of the N-terminus {as an CY- 
helix) out to the beginning of the first strand of the b- 
sheet. Two points must be recalled. Low pH treatment 
does not cause the trimer to dissociate [l l] and it does 
not change the overall a-helix or P-sheet content of HA 
[lo]. While the morphology of HA (X-31) on isolated 
virus eventually changes at low pH [9-l 11, these 
changes need not reflect the situation of HA at the fu- 
sion site with an apposed membrane. Thus, if HA re- 
mains ‘upright’ during fusion, then the site of action of 
the fusion peptides might well be between the apposed 
membranes, where their hydrophobic potential draws 
the lipids from both membranes intothe middle of the 
fusion site. 
3. DISCUSSION 
This proposal differs from the traditional view that 
fusion is initiated by the insertion of the fusion peptide 
into either the target membrane ~7,8,11-14,26,27] or
the viral membrane [9,10,13]. As shown in Fig. 3, addi- 
tional conformational changes to HA need to be 
postulated in order to permit the fusion peptide to reach 
3 
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either of the two membranes. In our model, only the ex- 
posure of the fusion peptide is required. In this sense, 
our model proposes a minimal change to the known 
neutral pH structure of HA in order to explain its fu- 
sion activity. 
Recent studies by Brunner and colleagues are 
especially interesting. They have used a lipid bound 
photoactivatable carbene probe to show that the fusion 
peptide sequence of BHA binds on& to the outer 
monolayer of Iiposomes and does so with only one side 
of the o-helix embedded into that monolayer [14,15]. 
This is reasonable, since an apolar sequence xposed on 
a soluble protein will seek a hydrophobic environment, 
i.e. either a lipid bilayer or through self-aggregation 
[lo, 141. However, this does not necessarily imply that 
the fusion peptide of the intact HA in a membrane will 
also insert into an apposing membrane, since HA does 
not have the same rotational freedom as BHA. On the 
other hand, this is precisely the depth of interaction and 
the configuration required by our model (Fig. 2) for the 
fusion peptide on HA, i.e. where one side of the a-helix 
faces water and the other side faces the acyl chains of 
the lipids. 
In fact, it is not obvious how insertion of a few am- 
phipathic a-helices into the outer monolayers of either 
or both apposed membranes generates the required 
destabilization. In pure lipid systems, these bilayers are 
stable down to 5 A separation [ZS]. Peptides 
homologous to those found on the N-terminus of HA2 
do destabilize small sonicated liposomes (SW) at low 
pH [8,13). It is known that WV are typically more 
unstable than larger liposomes 1291. Even so, 
destabilization required very high peptide-to-lipid 
ratios, where lysis is followed by lipid mixing. In fact, 
the action of these peptides at low pH is rather similar 
to the action of detergents like cholate or octylglucoside 
[30], An analogous 20 amino acid peptide, which 
becomes o-helical at low pH, has been estimated to pro- 
duce -0.5-l nm pores in liposomes, with about 8-12 
peptides being required to form each pore [31]. This 
behaviour is not consistent with the fusion induced by 
HA. In our view, the position of the fusion peptide 
within the fusion site is at least as important as its 
hydrophobicity and secondary structure. 
Several different experimental approaches will be re- 
quired to elucidate the architecture of the fusion site. 
Our model proposes that the lipids wet the proteins at 
the fusion site, rather than having the lipid bilayers 
spontaneously fuse following insertion of the fusion 
peptide. In principle, experiments using lipid bound 
photoactivatable carbene probes, such as those per- 
formed on BHA (14,151 and Sendai virus [32J, would be 
useful, in that the wetted proteins would be labelled at 
both the fusion peptide and at other sites along HA. 
However, these experiments will not be simpIe to per- 
form or to analyze. Firstly, it will be essential to cor- 
relate the labeling kinetics with the fusion kinetics, since 
4 
postfusion conformational changes of HA may well oc- 
cur. Secondly, it is essential to recall that while there are 
many HAS within the area of membrane contact, very 
few will be involved in fusion. Those not involved in fu- 
sion may well be labeiled by the probe. 
To conclude, the sequence of fusion intermediates 
shown in Fig. 2 begins the task of minimizing the ther- 
modynamic costs of breaking open bilayers in order to 
achieve fusion. The exposure of acyl chains to water can 
be alleviated by proposing more extensive conforma- 
tional changes to HA than we have done here. This 
becomes reasonable once more is known about the low 
pH, fusogenic conformation of HA. Using the crystal 
structure of HA, we can examine how the surface of 
this protein, as an element of the HA aggregate, might 
facilitate the flow of lipids between the bilayers. This 
knowledge will be invaluable in elucidating how other 
proteins induce fusion, since the ‘collar’ would appear 
to be an excellent candidate for a general architecture of 
fusion sites, even for eukaryotic systems [4J. 
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